FDA Inspection 1055011 — New Zealand Pharmaceutical Ltd.
The FDA completed an inspection of New Zealand Pharmaceutical Ltd. on May 25, 2018 in Palmerston North. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 25, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Palmerston North (New Zealand)